We are the "Excellence PROMETHEUS PHASE II Group" of the GVA, G24 member of the Networked Biomedical Research Centre on Mental Health (CIBERSAM-ISCIII). Since 2013 we are active partners in Europe within the European Innovation Partnership on Active and Healthy Ageing (Acción 3) Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA) Programme; we actively participate in defining a clinically useful position on Mild Cognitive Decline. We direct and coordinate the Assessment Unit for Personal Autonomy, Dependency and Mental Disorders (TMAP) located at the Faculty of Medicine UCIM-INCLIVA, with a service offer including biomechanical and neurocognitive assessments as part of the prevention of fragility signs in populations at risk. The TMAP Unit is the pioneer in carrying out and implementing assessments for patients with mental disorders and / or cognitive and functional deterioration in a comprehensive and personalised manner. These assessments are necessary to determine how people cope with everyday activities in case of disease or deterioration, and to provide them with useful information in order to apply measures allowing for an healthy and independent life.

From the group's formation in 2001 to its consolidation in 2007, work was carried out to contribute to the knowledge of cognitive and functional deficits of serious mental illnesses, with a special focus on schizophrenic and bipolar patients and their first-degree relatives. Currently, our knowledge is also focused on direct and inverse Multimorbidity in patients with complex diseases such as CNS disorders, cancer or metabolic diseases. The group can also be found in research areas such as: studies on disease burden (Global Burden of Disease studies), systematic review and networked meta-analysis, neurogenetics and cell therapy (stem cells,) and, finally, Nutritional Psychiatry.

Other personal service activities n.e.c.